Decitabine dosage in myelodysplastic syndromes
- PMID: 17644750
- DOI: 10.1182/blood-2007-03-080903
Decitabine dosage in myelodysplastic syndromes
Comment on
-
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.Blood. 2007 Jan 1;109(1):52-7. doi: 10.1182/blood-2006-05-021162. Epub 2006 Aug 1. Blood. 2007. PMID: 16882708 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

